Gain Therapeutics Inc. (GANX) NASDAQ

$3.77 0.04 (1.07%)

Market Cap: $60.50M

As of 03/28/24 04:00 PM EDT. Market closed.

(GANX)

Gain Therapeutics Inc. (GANX)
NASDAQ

$3.77
0.04 (1.07%)

Market Cap: $60.50M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

gain therapeutics is a preclinical stage biotech company specializing in the discovery of new drugs for orphan diseases. the company targets inborn errors of metabolism; a group of rare diseases of genetic origin with a high unmet medical need. gain therapeutics is also working on a new class of compounds: non-competitive pharmacological chaperones, identified through its innovative proprietary ... read more

gain therapeutics is a preclinical stage biotech company specializing in the discovery of new drugs for orphan diseases. the company targets inborn errors of metabolism; a group of rare diseases of genetic origin with a high unmet medical need. gain therapeutics is also working on a new class of compounds: non-competitive pharmacological chaperones, identified through its innovative proprietary platform – see-tx. the gain therapeutics team is made up of a group of drug discovery and development experts with several decades of experience in biotech and pharma. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
27
Address
.
PRICE CHART FOR GAIN THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.75
Previous Close
$3.73
Days Range
$3.65 - $3.84
52 week range
$2 - $6.19
Volume
102,217
Avg. Volume (30 days)
145,428
Market Cap
$60.50M
Dividend Yield
-
P/E
(2.72)
Shares Outstanding
16,219,709
Open
$3.75
Previous Close
$3.73
Days Range
$3.65 - $3.84
52 week range
$2 - $6.19
Volume
102,217
Avg. Volume (30 days)
145,428
Market Cap
$60.50M
Dividend Yield
-
P/E
(2.72)
Shares Outstanding
16,219,709
FINANCIAL STATEMENTS FOR GAIN THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR GAIN THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Alder MatthiasChief Executive OfficerDec 21, 2023 Sale$2.462065075,286Dec 22, 2023, 04:17 PM
Alder MatthiasChief Executive OfficerDec 07, 2023 Sale$2.501,8204,5504,855Dec 14, 2023, 04:01 PM
RICHMAN ERIC ICHIEF EXECUTIVE OFFICERMay 25, 2022 Buy$2.582,4826,404217,729May 27, 2022, 04:10 PM
RICHMAN ERIC ICHIEF EXECUTIVE OFFICERMay 20, 2022 Buy$2.839,25626,194215,247May 23, 2022, 04:41 PM
RICHMAN ERIC ICHIEF EXECUTIVE OFFICERMay 19, 2022 Buy$2.714,00010,840205,991May 23, 2022, 04:41 PM
Calabrese SalvatoreCHIEF FINANCIAL OFFICERMay 19, 2022 Buy$2.703,0008,1003,000May 23, 2022, 04:00 PM
Calabrese SalvatoreCHIEF FINANCIAL OFFICERMay 19, 2022 Buy$8100.003,00024,300,0008,100May 19, 2022, 05:00 PM
RICHMAN ERIC IChief Executive OfficerAug 16, 2021 Buy$7.874,92238,716216,820Apr 21, 2022, 04:50 PM
RICHMAN ERIC IDirectorAug 16, 2021 Option Exercise$7.874,92238,716216,820Aug 17, 2021, 09:03 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Alder MatthiasChief Executive Officer12/21/2023507
Alder MatthiasChief Executive Officer12/07/20234,550
RICHMAN ERIC ICHIEF EXECUTIVE OFFICER05/25/20226,404
RICHMAN ERIC ICHIEF EXECUTIVE OFFICER05/20/202226,194
RICHMAN ERIC ICHIEF EXECUTIVE OFFICER05/19/202210,840
Calabrese SalvatoreCHIEF FINANCIAL OFFICER05/19/20228,100
Calabrese SalvatoreCHIEF FINANCIAL OFFICER05/19/202224,300,000
RICHMAN ERIC IChief Executive Officer08/16/202138,716
RICHMAN ERIC IDirector08/16/202138,716
FUNDS WITH A POSITION IN GAIN THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GREENLIGHT CAPITAL INC588,4100.09%No changeActivists
GEODE CAPITAL MANAGEMENT, LLC151,4760.00005%No changeOther
RENAISSANCE TECHNOLOGIES LLC42,8000.00022%-8.74%Other
BLACKROCK INC.27,6110%-1.12%Other
CHANGE IN SHARES OUTSTANDING FOR GAIN THERAPEUTICS INC
STOCK BUYBACKS FOR GAIN THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
18.25%
1Q
12/31/2023
06/30/2023
21.25%
2Q
12/31/2023
03/31/2023
25.84%
3Q
12/31/2023
12/31/2022
26.39%
4Q
12/31/2023
09/30/2022
26.39%
5Q
12/31/2023
06/30/2022
26.39%
6Q
12/31/2023
03/31/2022
26.39%
7Q
12/31/2023
12/31/2021
26.21%
8Q
12/31/2023
09/30/2021
26.46%
9Q
12/31/2023
06/30/2021
26.46%
10Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
18.25%
1Q
06/30/2023
21.25%
2Q
03/31/2023
25.84%
3Q
12/31/2022
26.39%
4Q
09/30/2022
26.39%
5Q
06/30/2022
26.39%
6Q
03/31/2022
26.39%
7Q
12/31/2021
26.21%
8Q
09/30/2021
26.46%
9Q
06/30/2021
26.46%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR GAIN THERAPEUTICS INC
LOADING...